Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulation

Molecular Cell(2022)10.1016/j.molcel.2022.10.016Source: DataRank Database

RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulation is a research paper published in Molecular Cell (2022). On theSindex it has a DataRank of 0. It has been cited 44 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access44 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.98)OA: greenTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Elizabeth M. Terrell,Christine Insinna,Constance Agamasu,Morgan E. Wagner ORCID,Daniel A. Ritt

Live enrichment

PubMed:36347258 PMC:PMC9677513 OpenAlex:https://openalex.org/W4308437122

National Cancer Institute

Grant: HHSN261200800001E

National Cancer Institute

Grant: ZIA BC 010329

Intramural NIH HHS

Grant: Z01 BC010329

CCR NIH HHS

Grant: HHSN261200800001C

National Institutes of Health

FWCI

2.98

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9677513

publisherhttps://api.elsevier.com/content/article/PII:S1097276522010164?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1097276522010164?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.molcel.2022.10.016

Fields of Study

Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways

MeSH Terms

Protein DomainsCysteineHumansMutationSyndromeProto-Oncogene Proteins B-raf

Keywords

BiologyMutationCancer researchFunction (biology)CysteineMediatorPhosphatidylserineCell biologyGeneticsGeneBiochemistryEnzymeMembraneDevelopmentRasBrafCrdRasopathiesAutoinhibitionRaf KinasesCrafCysteine-rich Domain

Sustainable Development Goals

SDG 0: Good health and well-being

RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulation

FAIR Checklist

Authors (9)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)